ATE346917T1 - Verfahren zum screenen von verbindungen, welche die expression der menschlichen induzierbaren stickstoffoxidsynthase regulieren - Google Patents

Verfahren zum screenen von verbindungen, welche die expression der menschlichen induzierbaren stickstoffoxidsynthase regulieren

Info

Publication number
ATE346917T1
ATE346917T1 AT97941189T AT97941189T ATE346917T1 AT E346917 T1 ATE346917 T1 AT E346917T1 AT 97941189 T AT97941189 T AT 97941189T AT 97941189 T AT97941189 T AT 97941189T AT E346917 T1 ATE346917 T1 AT E346917T1
Authority
AT
Austria
Prior art keywords
expression
hinos
gene
oxide synthase
transformant
Prior art date
Application number
AT97941189T
Other languages
English (en)
Inventor
Youichi Nunokawa
Shinzo Oikawa
Shoji Tanaka
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Application granted granted Critical
Publication of ATE346917T1 publication Critical patent/ATE346917T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/02Quinones with monocyclic quinoid structure
    • C07C50/06Quinones with monocyclic quinoid structure with unsaturation outside the quinoid structure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/26Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/30Quinones containing groups having oxygen atoms singly bound to carbon atoms with polycyclic non-condensed quinoid structure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C12N9/0075Nitric-oxide synthase (1.14.13.39)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT97941189T 1996-09-20 1997-09-18 Verfahren zum screenen von verbindungen, welche die expression der menschlichen induzierbaren stickstoffoxidsynthase regulieren ATE346917T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25069796 1996-09-20

Publications (1)

Publication Number Publication Date
ATE346917T1 true ATE346917T1 (de) 2006-12-15

Family

ID=17211706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97941189T ATE346917T1 (de) 1996-09-20 1997-09-18 Verfahren zum screenen von verbindungen, welche die expression der menschlichen induzierbaren stickstoffoxidsynthase regulieren

Country Status (7)

Country Link
US (1) US6203982B1 (de)
EP (1) EP0864648B1 (de)
JP (1) JP4100712B2 (de)
AT (1) ATE346917T1 (de)
DE (1) DE69737014T2 (de)
ES (1) ES2274548T3 (de)
WO (1) WO1998012313A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11266872A (ja) * 1998-03-20 1999-10-05 Suntory Ltd NF−κBの活性化を抑制する物質のスクリーニング方法
CN1181817C (zh) 1998-03-20 2004-12-29 第一三得利制药株式会社 以苯基甲苯醌为有效成分的NF-kB抑制剂
AU5113499A (en) * 1998-07-21 2000-02-14 Duke University Transgenic model of human oxidative stress
US6610503B1 (en) 1999-03-17 2003-08-26 Xenogen Corporation Animal models for predicting sepsis mortality
US7078171B2 (en) * 2000-04-28 2006-07-18 Message Pharmaceutical, Inc. Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
US8460864B2 (en) 2003-01-21 2013-06-11 Ptc Therapeutics, Inc. Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US8426194B2 (en) * 2003-01-21 2013-04-23 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating VEGF expression
US9068234B2 (en) * 2003-01-21 2015-06-30 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating gene expression
MXPA06003666A (es) * 2003-10-03 2006-08-31 Johnson & Johnson Gen 1 eliminado en tumores cerebrales malignos como marcador clinico, y usos del mismo.
US8283115B1 (en) 2007-06-20 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en) 2007-06-22 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506337B2 (ja) * 1986-06-06 1996-06-12 サントリー株式会社 フエニルメチルベンゾキノン誘導体
EP0670902A1 (de) * 1992-11-25 1995-09-13 University Of Pittsburgh Of The Commonwealth System Of Higher Education FÜR MENSCHLICHE INDUZIERBARE STICKSTOFFOXYDESYTHASE KODIERENDE cDNA UND VERFAHREN ZUR HERSTELLUNG DAVON
GB9306386D0 (en) * 1993-03-26 1993-05-19 Wellcome Found Gene expression
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA

Also Published As

Publication number Publication date
US6203982B1 (en) 2001-03-20
DE69737014T2 (de) 2007-06-28
EP0864648B1 (de) 2006-11-29
WO1998012313A1 (en) 1998-03-26
ES2274548T3 (es) 2007-05-16
DE69737014D1 (de) 2007-01-11
JP4100712B2 (ja) 2008-06-11
EP0864648A4 (de) 2002-10-30
EP0864648A1 (de) 1998-09-16

Similar Documents

Publication Publication Date Title
ATE346917T1 (de) Verfahren zum screenen von verbindungen, welche die expression der menschlichen induzierbaren stickstoffoxidsynthase regulieren
AT380833B (de) Verfahren und schaltungsanordnung zum steuern der speisung bzw. erregung von druckkoepfen
DE68913624D1 (de) Verfahren zum Regeln des Aufrollens von photographischem Material.
DE69328139D1 (de) Verfahren zum Beizen und Passivieren von rostfreiem Stahl ohne Verwendung von Salpetersäure
FR2481863B1 (fr) Amplificateur haute frequence fonctionnant en classe c sous haute tension
DE3871004D1 (de) Verfahren und apparat zur regelung der speisestroeme der argonkolonne.
BE845928A (fr) Procede de controle non destructif par courants de foucault et dispositif correspondant, utilisant une excitation multifrequence et permettant l'elimination de certains parametres
ATE251233T1 (de) Verfahren und vorrichtung zum sputtern von magnetischem targetmaterial
PT65378A (fr) Procede de jonction de barres metalliques avec des blocs de carbone
FI51715C (fi) Menetelmä ja laitteisto rauta- ja teräsvalmisteiden karkaisemisksi ja kuumasinkitsemiseksi samanaikaisesti.
DE69128624D1 (de) Verfahren zum Herstellen von normal kornorientiertem Stahl mit hohem Silizium- und niedrigem Kohlenstoffgehalt
IT1078575B (it) Processo e soluzione per la zincatura
AT295566B (de) Verfahren und Vorrichtung zur kontinuierlichen Herstellung von flüssigem Stahl unter Verwendung von Lichtbogenöfen
CH442766A (de) Verfahren zur Herstellung von unmagnetischem Stahl sowie nach diesem Verfahren hergestellter Stahl
FI814136A7 (fi) Menetelmä puutavarakappaleiden tasaamiseksi sekä laite menetelmän suorittamiseksi.
JPS5222304A (en) Apparatus for controlling location of steel pillar erected in pit
DE3889232D1 (de) Verfahren zum quantitativen Nachweis von Sauerstoff.
PL199935A1 (pl) Sposob sterowania procesem swiezenia stali o zawartosci wegla 0,1-0,8%
JPS524627A (en) Method of correcting verticalness of steel frame pillar
SU553306A1 (ru) Способ цинковани стальной проволоки
DE3168450D1 (en) Process for stabilising the current gain of npn transistors
Sadovskii et al. Thermomechanical-Magnetic Treatment of Metastable Austenitic Steels
SU878419A1 (ru) Способ определени оптимальной термо-ЭДС
JPS5279994A (en) Detecting method of coins or the like
AT363297B (de) Verfahren zur aufbereitung von schwefelsaeure, welche eisen in form geloesten sulfats enthaelt

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0864648

Country of ref document: EP

EEFA Change of the company name